ArticleJournal of medical ultrasound
Thyroid Imaging Reporting and Data System on the Basis of Cost and Effectiveness.
Article in Journal of medical ultrasound. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Assessment of Potentially Unnecessary Breast Magnetic Resonance Imaging Utilization and Its Economic Impact: A Retrospective Study.The Eurasian journal of medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: We aim to evaluate thyroid imaging reporting and data system (TIRADS) on the basis of cost and effectiveness through the numbers of fine-needle aspiration biopsies (FNABs) and sonographic examinations in a tertiary health-care institution. Methods: The 50-day intervals before and after the start of TIRADS use (October 10, 2022) were evaluated to carry out this assessment. The reason for choosing 50-day periods was because it covers the initial phase when the study is most optimally performed in our hospital. The number of thyroid ultrasound (US) and FNAB procedures carried out in our facility during that time was tallied. Exclusion standards were not applied. Results: One thousand nine hundred eighty-two people made up the study population. Fifty days before the October 10, 2022, there were 975 instances (49.2%), and 50 days after that, there were 1007 cases (50.8%). Out of 1982 cases, it was discovered that 190 (9.6%) underwent a biopsy, and 1792 (90.4%) underwent a US examination. It was found that the first period's rate of biopsy examination was significantly higher than the second period's rates of 11.1% and 8.1%, respectively. The rate of biopsy examination in males during the first period was found to be substantially higher than the second period. Individuals between the ages of 35 and 50 years had a rate of biopsy examination that was considerably higher in the first period than the second period. Conclusion: The TIRADS Risk Scale has the capacity to reduce unnecessary biopsies, hence mitigating potential psychological distress, burden, and financial expenses for the patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.